 |
Alnylam Pharmaceuticals Inc |
Company profile |
|
Analysis : [Random Walk] [Default Prediction] [Fundamental Analysis]
|
Price Prediction |
Random walk modeling for 2008 (what's this?). Click on the images for the high resolution version.
| Initial Value* : |
$29.08 |
Historic Volatility : |
3.69% |
Annual Drift : |
7% |
 
* Stock quotes on TextBiz are always adjusted close prices (what's this?).
|
Money Flow Index |
Money FLow Index for 2008
* To learn more about Money Flow Index (what's this?).
|
Default Prediction for 2007-12-31 |
|
Default prediction by Z-Score (what's this?).
Sector Industry
 
View the other companies in the same industry : Biotechnology & Drugs
Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):
For manufacuring companies:
Sector Industry
  |
For non-manufacturing companies:
Sector Industry
  |
|
Fundamental Analysis for 2007- |
|
Fundamental Analysis measures (what's this?).
Date of financial statements used: 2007-12-31 |
| Book Value : |
$198.200 M |
Internal Value : |
$198.200 M |
Working Capital : |
$381.468 M |
| Debt to Asset Ratio : |
0.597 |
Current Ratio: |
0.177 |
Turnover Ratio: |
N/A |
| Net Margins : |
-2.382 |
EPS : |
-4.254 |
P/E ratio : |
-7.174 |
| P/B ratio : |
3.094 |
ROE : |
-0.431 |
ROA : |
-0.173 |
|
